BESCH C.
- Country
- France
- Department
- Hepato-gastroenterologie
Research Overview
- Evaluation of Tacrolimus and Mycophenolate Mofetil in Immunosuppressive Regimens for Liver Transplant Recipients: A Comparative Study
- Evaluation of Atezolizumab and Bevacizumab Safety in Liver Transplant Recipients with Advanced Hepatocellular Carcinoma
- A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma and Complete Radiological Response after Surgical Resection or Local Ablation (KEYNOTE-937)
Data & Insights
Has run more than one trial at 9 of 61 partner sites.
Specializations
Liver Oncology
This investigator specializes in treating advanced hepatocellular carcinoma, with particular focus on patients who have undergone liver transplantation. Their research encompasses innovative therapeutic approaches for managing post-transplant cancer recurrence.
- Post-transplant HCC Management
- Advanced Liver Cancer Therapies
- Immunotherapy Applications
The investigator explores treatment options for both primary and recurrent liver cancer scenarios.
Transplant Medicine
The investigator focuses on optimizing immunosuppressive strategies in liver transplant recipients. Their work involves developing and evaluating novel approaches to post-transplant medication regimens.
- Immunosuppression Optimization
- Post-Transplant Care
- Drug Administration Protocols
Their research extends to improving long-term outcomes for transplant recipients through medication management.
Immunotherapy Research
The investigator studies novel immunotherapeutic approaches in liver cancer treatment, including both adjuvant therapy and advanced disease management.
- Combination Immunotherapy
- Post-Surgical Treatment
- Cancer Recurrence Prevention
Their work includes evaluation of various immunotherapy agents in different clinical contexts.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.